Abstract
Type II diabetes mellitus (T2DM) is closely associated with Obstructive sleep apnea (OSA) and obesity. Type 2 diabetes and OSA may be pathophysiologically independent conditions although the joint association with obesity or visceral adiposity. There is a consistent relationship between obesity and OSA, which has been reported in 60-90% of OSA patients. The prevalence of obesity increases with a parallel increase in the prevalence of OSA. Continuous positive airway pressure (CPAP) therapy is an effective choice of treatment for OSA, an overnight test, or titration some patients may reduce apnea events by minimizes airway collapse by CPAP. Several studies showed that the effect of drug treatment with 3 months of C-PAP in patients with type 2 diabetes. In the present study, we include 300 patients in different groups, out of the 100 patients undergoing treatment of CPAP therapy minimum for three months. Blood sugar, HbA1c, and lipid profile were measured and an overnight sleep study was done. The obtained data shows the significant effect of therapy on physiological and biochemical parameters. AHI and BMI were highly significant in group II and Group III when compared to group I. FBS, HbA1C, and Lipid profile parameters also gave significance results (p-value <0.001) in group II and group III when compared with healthy subjects (group I).
References
Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2-diabetes: interacting epidemics. Chest 2008;133:496-506.
Philip G, Ternan MC, Anwar A and Sudesh Kumar. ‘Relationship between fat distribution and insulin resistance’. (Text Book); p 207-225, 2005.
Tantawy H. Nutritional diseases and inborn errors of metabolism. In: Hines RL, Marschall KE, eds. Stoelting’s Anesthesia and Co-existing Disease. Philadelphia, PA: Churchill Livingstone, 2008;297-322.
Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62:569-76.
The Report of an American Academy of sleep medicine task force: sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. (1999). SLEEP, 22(5), 667-689.
Punjabi N, Caffo B, Goodwin J, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.
Littner M, Hirshkowitz M, Davila D, et al. "Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report". Sleep 2002;25 (2):143-7.
Sophie D West, Debby J Nicoll, Tara M Wallace, David R Matthews, John R Stradling, Thorax 2007;62:969–974. doi: 10.1136/thx.2006.074351.
Arnaud C, Dematteis M, Pepin J-L, Baguet J-P, Lévy P. Obstructive sleep apnea, immune-inflammation and atherosclerosis. Semin Immunopathol. 2009;31:113-125.
Stamatakis KA, Punjabi NM. Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010; 137: 95-101.
Lévy P, Pépin J, Arnaud C, et al. Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 2008;32:1082-95.
Ambika r. Babu et al arch intern med/ vol 165, feb 28, 2005;165:447-452.
Adriana R, Cristina N, Nicolae H. Sleep Apnea and type 2 diabetes a short review of the literature. Romanian Journal of Diabetes Nutrition & Metabolic Diseases / Vol. 19 / no. 1 / 2012 :73-80
Nikolaos P, Paschalis S, Evangelia N et al. HbA1c is associated with the severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vascular Health and Risk Management 2009;5:751-756.
Tamura A, Kawano Y, Watanabe T, Kadota J. Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med. 2012;13:1050-55.
Aronshohn RS et al, Am J Respir Crit Care Med. 2010] Mar 1;181(5):507-13
Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 2005;9:176-80.
Alan R. Schwartz, Susheel P. Patil et al, PROCEEDINGS OF THE AMERICAN THORACIC SOCIETY Vol 5. pp 185–192, 2008.
Foster GD, Sanders MH, Millman R et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017-1019.
Lui MMS, Ip MSM. Disorders of glucose metabolism in sleep-disordered breathing. Clin Chest Med. 2010;31:271-285.
Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176:706-12.
How to cite this article:
Sarkar PD, Kumar A, Gopal K, Kachhawa P and Singh S. The study of the effect of C-PAP therapy in type-II diabetic patients with obesity and obstructive sleep apnea. Int. J. Res. Dev. Pharm. L. Sci. 2019; 8(4): 18-21. doi: 10.13040/IJRDPL.2278-0238.8(4).18-21
This Journal is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array